Abbott To Pay $1.6B To Settle Depakote Allegations
By Megan Stride ( May 7, 2012, 4:10 PM EDT) -- Abbott Laboratories Inc. pled guilty to drug misbranding and agreed to pay $1.6 billion on Monday to resolve state and federal investigations into its off-label marketing of the anti-seizure drug Depakote and related kickback and false claims allegations....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.